Aurora-A overexpression associates with Ha-ras codon-12 mutation and blackfoot disease endemic area in bladder cancer

Cancer Letters

Volumn 241, Issue 1, 2006, Pages 93-101

  Tseng, Ya Shih ^a,d   Tzeng, Ching Cherng ^b   Huang, Chi Ying F ^c   Chen, Ping Hong ^a   Chiu, Allen Wen Hsiang ^b   Hsu, Pei Yin ^a   Huang, Guan Cheng ^a,b   Wang, Yu Chun ^b   Liu, Hsiao Sheng ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d DIWAN COLLEGE OF MANAGEMENT   (Taiwan)

Author keywords

Arsenic; Aurora A; Blackfoot endemic area; Ha ras mutation

Indexed keywords

ARSENIC; AURORA KINASE; MESSENGER RNA; PROTEIN SERINE THREONINE KINASE;

ARTICLE; CELL TRANSFORMATION; CODON; ENDEMIC DISEASE; GENETICS; HUMAN; MUTATION; ONCOGENE RAS; PERIPHERAL VASCULAR DISEASE; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR CELL LINE;

ARSENIC; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CODON; ENDEMIC DISEASES; GENES, RAS; HUMANS; MUTATION; PERIPHERAL VASCULAR DISEASES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; RNA, MESSENGER;

EID: 39049177016     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.10.014     Document Type: Article

References (40)

1. Giet R., Prigent C. Aurora/Ipl1p-related kinases, a new oncogenic family of mitotic serine-threonine kinases. J. Cell Sci. 1999, 112:3591-3601.
2. Adams R.R., Carmena M., Earnshaw W.C. Chromosomal passengers and the (aurora) ABCs of mitosis. Trends Cell. Biol. 2001, 11:49-54.
3. Katayama H., Brinkley W.R., Sen S. The Aurora kinases: role in cell transformation and tumorigenesis. Cancer Metastasis Rev. 2003, 22:451-464.
4. Kimura M., Kotani S., Hattori T., Sumi N., Yoshioka T., Todokoro K., et al. Cell cycle-dependent expression and spindle pole localization of a novel human protein kinase, Aik, related to Aurora of Drosophila and yeast Ipl1. J. Biol. Chem. 1997, 272:13766-13771.
5. Bischoff J.R., Anderson L., Zhu Y., Mossie K., Ng L., Souza B., et al. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. Eur. Mol. Biol. Org. J. 1998, 17:3052-3065.
6. Zhou H., Kuang J., Zhong L., Kuo W.L., Gray J.W., Sahin A., et al. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat. Genet. 1998, 20:189-193.
7. Shields J.M., Pruitt K., McFall A., Shaub A., Der C.J. Understanding Ras: it ain't over til it's over. Trends Cell Biol. 2000, 10:147-154.
8. Feig L.A., Buchsbaum R.J. Cell signaling: life or death decisions of ras proteins. Curr. Biol. 2002, 12:R259-R261.
9. Spandidos D.A., Sourvinos G., Tsatsanis C., Zafiropoulos A. Normal ras genes: their onco-suppressor and pro-apoptotic functions (review). Int. J. Oncol. 2002, 21:237-241.
10. Campbell S.L., Khosravi-Far R., Rossman K.L., Clark G.J., Der C.J. Increasing complexity of Ras signaling. Oncogene 1998, 17:1395-1413.
11. Bos J.L. Ras oncogenes in human cancer: a review. Cancer Res. 1989, 49:4682-4689.
12. Chang M.Y., Jan M.S., Won S.J., Liu H.S. Ha-rasVal12 oncogene increases susceptibility of NIH/3T3 cells to lovastatin. Biochem. Biophys. Res. Commun. 1998, 248:62-68.
13. Chang M.Y., Won S.J., Yang B.C., Jan M.S., Liu H.S. Selective activation of Ha-ras(val12) oncogene increases susceptibilityof NIH/3T3 cells to TNF-alpha. Exp. Cell Res. 1999, 248:589-598.
14. Liu H.S., Chen C.Y., Lee C.H., Chou Y.I. Selective activation of oncogenic Ha-ras induced apoptosis in NIH/3T3 cells. Br. J. Cancer 1998, 77:1777-1786.
15. Tseng Y.S., Tzeng C.C., Chiu A.W., Lin C.H., Won S.J., Wu I.C., et al. Ha-ras overexpression mediated cell apoptosis in the presence of 5-fluorouracil. Exp. Cell Res. 2003, 288:403-414.
16. Zhang Z.T., Pak J., Huang H.Y., Shapiro E., Sun T.T., Pellicer A., et al. Role of Ha-ras activation in superficial papillary pathway of urothelial tumor formation. Oncogene 2001, 20:1973-1980.
17. Ch'i I.C., Blackwell R.Q. A controlled retrospective study of Blackfoot disease, an endemic peripheral gangrene disease in Taiwan. Am. J. Epidemiol. 1968, 88:7-24.
18. Chen K.P., Wu H.Y. Epidemiologic studies on blackfoot disease in Taiwan, China. 6. Effect of the piped water supply on occurrence and disease progress of blackfoot disease. Taiwan Yi Xue Hui Za Zhi 1969, 68:291-295.
19. Tseng W.P. Prognosis of blackfoot disease. A 10-year follow-up study. Taiwan Yi Xue Hui Za Zhi 1970, 69:1-21.
20. Lu F.J., Yang C.K., Ling K.H. Physico-chemical characteristics of drinking water in blackfoot endemic areas in Chia-I and Tainan Hsiens. Taiwan Yi Xue Hui Za Zhi 1975, 74:596-605.
21. Chen C.J., Chuang Y.C., You S.L., Lin T.M., Wu H.Y. A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan. Br. J. Cancer 1986, 53:399-405.
22. P Tseng W. Effects and dose-response relationships of skin cancer and blackfoot disease with arsenic. Environ. Health Perspect. 1977, 19:109-119.
23. Chen C.J., Chuang Y.C., Lin T.M., Wu H.Y. Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. Cancer Res. 1985, 45:5895-5899.
24. Wu M.M., Kuo T.L., Hwang Y.H., Chen C.J. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am. J. Epidemiol. 1989, 130:1123-1132.
25. Chiang P.H., Huang M.S., Tsai C.J., Tsai E.M., Huang C.H., Chiang C.P. Transitional cell carcinoma of the renal pelvis and ureter in Taiwan. DNA analysis by flow cytometry. Cancer 1993, 71:3988-3992.
26. Chiou H.Y., Hsueh Y.M., Liaw K.F., Horng S.F., Chiang M.H., Pu Y.S., et al. Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Res. 1995, 55:1296-1300.
27. Yang C.Y., Chiu H.F., Chang C.C., Ho S.C., Wu T.N. Bladder cancer mortality reduction after installation of a tap-water supply system in an arsenious-endemic area in southwestern Taiwan. Environ. Res. 2005, 98:127-132.
28. Sen S., Zhou H., Zhang R.D., Yoon D.S., Vakar-Lopez F., Ito S., et al. Amplification/overexpression of a mitotic kinase gene in human bladder cancer. J. Natl Cancer Inst. 2002, 94:1320-1329.
29. Tzeng C.C., Liu H.S., Li C., Jin Y.T., Chen R.M., Yang W.H., et al. Characterization of two urothelium cancer cell lines derived from a blackfoot disease endemic area in Taiwan. Anticancer Res. 1996, 16:1797-1804.
30. Senger D.R., Perruzzi C.A., Ali I.U. T24 human bladder carcinoma cells with activated Ha-ras protooncogene: nontumorigenic cells susceptible to malignant transformation with carcinogen. Proc. Natl Acad. Sci. USA 1988, 85:5107-5111.
31. Tatsuka M., Sato S., Kitajima S., Suto S., Kawai H., Miyauchi M., et al. Overexpression of Aurora-A potentiates HRAS-mediated oncogenic transformation and is implicated in oral carcinogenesis. Oncogene 2004, 24:1122-1127.
32. Saavedra H.I., Fukasawa K., Conn C.W., Stambrook P.J. MARK mediates RAS-induced chromosome instability. J. Biol. Chem. 1999, 274:38083-38090.
33. Saavedra H.I., Knauf J.A., Shirokawa J.M., Wang J., Ouyang B., Elisei R., et al. The RAS oncogene induces genomic instability in thyroid PCCL3 cells via the MAPK pathway. Oncogene 2000, 19:3948-3954.
34. Yih L.H., Peck K., Lee T.C. Changes in gene expression profiles of human fibroblasts in response to sodium arsenite treatment. Carcinogenesis 2002, 23:867-876.
35. Simeonova P.P., Wang S., Toriuma W., Kommineni V., Matheson J., Unimye N., et al. Arsenic mediates cell proliferation and gene expression in bladder epithelium: association with activating protein-1 transactivation. Cancer Res. 2000, 60:3445-3453.
36. Dutertre S., Descamps S., Prigent C. On the role of aurora-A in centrosome function. Oncogene 2002, 21:6175-6183.
37. Liou S.H., Lung J.C., Chen Y.H., Yang T., Hsieh L.L., Chen C.J., et al. Increased chromosome-type chromosome aberration frequencies as biomarkers of cancer risk in a blackfoot endemic area. Cancer Res. 1999, 59:1481-1484.
38. Felix K., Manna S.K., Wise K., Barr J., Ramesh G.T. Low levels of arsenite activates nuclear factor-kappaB and activator protein-1 in immortalized mesencephalic cells. J. Biochem. Mol. Toxicol. 2005, 19:67-77.
39. L. Lin, T.M. Stringfield, X. Shi, Y. Chen, Arsenite induces a cell stress response gene RTP801 through reactive oxygen species and transcription factors Elk-1 and CCAAT/enhancer binding protein. Biochem. J. (Epub ahead of print) (2005).
40. Santillo P.M., Mondola R., Seru T., Annella S., Cassano I., Ciullo M.F., et al. Opposing functions of Ki- and Ha-Ras genes in the regulation of redox signals. Curr. Biol. 2001, 11:614-619.